105 related articles for article (PubMed ID: 38853565)
1. Rapidly reversible persistent long-term potentiation inhibition by patient-derived brain tau and amyloid ß proteins.
Ondrejcak T; Klyubin I; Hu NW; Yang Y; Zhang Q; Rodriguez BJ; Rowan MJ
Philos Trans R Soc Lond B Biol Sci; 2024 Jul; 379(1906):20230234. PubMed ID: 38853565
[TBL] [Abstract][Full Text] [Related]
2. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
[TBL] [Abstract][Full Text] [Related]
3. Soluble tau aggregates inhibit synaptic long-term depression and amyloid β-facilitated LTD in vivo.
Ondrejcak T; Hu NW; Qi Y; Klyubin I; Corbett GT; Fraser G; Perkinton MS; Walsh DM; Billinton A; Rowan MJ
Neurobiol Dis; 2019 Jul; 127():582-590. PubMed ID: 30910746
[TBL] [Abstract][Full Text] [Related]
4. Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau
Ondrejcak T; Klyubin I; Corbett GT; Fraser G; Hong W; Mably AJ; Gardener M; Hammersley J; Perkinton MS; Billinton A; Walsh DM; Rowan MJ
J Neurosci; 2018 Dec; 38(50):10595-10606. PubMed ID: 30355631
[TBL] [Abstract][Full Text] [Related]
5. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies.
Zhang D; Qi Y; Klyubin I; Ondrejcak T; Sarell CJ; Cuello AC; Collinge J; Rowan MJ
Neuropharmacology; 2017 Jul; 121():231-246. PubMed ID: 28390893
[TBL] [Abstract][Full Text] [Related]
6. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.
Puzzo D; Piacentini R; Fá M; Gulisano W; Li Puma DD; Staniszewski A; Zhang H; Tropea MR; Cocco S; Palmeri A; Fraser P; D'Adamio L; Grassi C; Arancio O
Elife; 2017 Jul; 6():. PubMed ID: 28696204
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.
Qi Y; Klyubin I; Harney SC; Hu N; Cullen WK; Grant MK; Steffen J; Wilson EN; Do Carmo S; Remy S; Fuhrmann M; Ashe KH; Cuello AC; Rowan MJ
Acta Neuropathol Commun; 2014 Dec; 2():175. PubMed ID: 25540024
[TBL] [Abstract][Full Text] [Related]
8. Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.
Acquarone E; Argyrousi EK; van den Berg M; Gulisano W; Fà M; Staniszewski A; Calcagno E; Zuccarello E; D'Adamio L; Deng SX; Puzzo D; Arancio O; Fiorito J
Mol Neurodegener; 2019 Jun; 14(1):26. PubMed ID: 31248451
[TBL] [Abstract][Full Text] [Related]
9. Gamma-patterned sensory stimulation reverses synaptic plasticity deficits in rat models of early Alzheimer's disease.
Yang Y; Ondrejcak T; Hu NW; Islam S; O'Rourke E; Reilly RB; Cunningham C; Rowan MJ; Klyubin I
Eur J Neurosci; 2023 Sep; 58(6):3402-3411. PubMed ID: 37655756
[TBL] [Abstract][Full Text] [Related]
10. Opposite in vivo effects of agents that stimulate or inhibit the glutamate/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Aß.
Zhang D; Jin B; Ondrejcak T; Rowan MJ
Hippocampus; 2016 Dec; 26(12):1655-1665. PubMed ID: 27701797
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau.
Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Guerrero-Munoz MJ; Kiritoshi T; Neugebauer V; Jackson GR; Kayed R
Sci Rep; 2012; 2():700. PubMed ID: 23050084
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.
Fá M; Puzzo D; Piacentini R; Staniszewski A; Zhang H; Baltrons MA; Li Puma DD; Chatterjee I; Li J; Saeed F; Berman HL; Ripoli C; Gulisano W; Gonzalez J; Tian H; Costa JA; Lopez P; Davidowitz E; Yu WH; Haroutunian V; Brown LM; Palmeri A; Sigurdsson EM; Duff KE; Teich AF; Honig LS; Sierks M; Moe JG; D'Adamio L; Grassi C; Kanaan NM; Fraser PE; Arancio O
Sci Rep; 2016 Jan; 6():19393. PubMed ID: 26786552
[TBL] [Abstract][Full Text] [Related]
13. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
Audrain M; Fol R; Dutar P; Potier B; Billard JM; Flament J; Alves S; Burlot MA; Dufayet-Chaffaud G; Bemelmans AP; Valette J; Hantraye P; Déglon N; Cartier N; Braudeau J
Mol Neurodegener; 2016 Jan; 11():5. PubMed ID: 26759118
[TBL] [Abstract][Full Text] [Related]
15. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
[TBL] [Abstract][Full Text] [Related]
16. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
17. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
Walsh DM; Klyubin I; Fadeeva JV; Cullen WK; Anwyl R; Wolfe MS; Rowan MJ; Selkoe DJ
Nature; 2002 Apr; 416(6880):535-9. PubMed ID: 11932745
[TBL] [Abstract][Full Text] [Related]
18. Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
Klyubin I; Ondrejcak T; Hayes J; Cullen WK; Mably AJ; Walsh DM; Rowan MJ
Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130147. PubMed ID: 24298149
[TBL] [Abstract][Full Text] [Related]
19. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein.
Barry AE; Klyubin I; Mc Donald JM; Mably AJ; Farrell MA; Scott M; Walsh DM; Rowan MJ
J Neurosci; 2011 May; 31(20):7259-63. PubMed ID: 21593310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]